 Lumos Pharma, Inc. LUMO, a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, today announced it will report its first quarter 2020 financial results after market close on Thursday, May 28, 2020. The company will host a conference call and webcast at 4:30 PM ET that day to discuss its first quarter financial results and provide an update on corporate activities. Investors and the general public are invited to listen to a live audio webcast of the conference call, which can be accessed five minutes prior to the start of the call by dialing 855 469-0612 U.S. or 484 756-4268 international. 